Investigator experiences with financial conflicts of interest in clinical trials

Paula A. Rochon; Melanie J. Sekeres; John Hoey; Joel Lexchin; Lorraine E. Ferris; David Moher; Wei Wu; Sunila R. Kalkar; Marleen Van Laethem; Andrea Gruneir; Jennifer Gold; James Maskalyk; David L. Streiner; Nathan Taback; An‐Wen Chan

doi:10.1186/1745-6215-12-9

Related publications

Article2010

Financial Conflicts of Interest Checklist 2010 for clinical research studies.

Paula A. Rochon, John Hoey, An‐Wen Chan, Lorraine E. Ferris, Joel Lexchin, Sunila R. Kalkar, Melanie J. Sekeres, Wei Wu, Marleen Van Laethem, Andrea Gruneir, James Maskalyk, David L. Streiner, Jennifer Gold, Nathan Taback, David Moher

Article2023

Industry Involvement and Transparency in the Most Cited Clinical Trials, 2019-2022

Leonardo Maria Siena, Lazaros Papamanolis, Maximilian Siebert, Rosa Katia Bellomo, John P A Ioannidis

Preprint2024

Genetic and other omics-based information in the most-cited recent clinical trials

Luigi Russo, Leonardo Maria Siena, Sara Farina, Roberta Pastorino, Stefania Boccia, John P A Ioannidis

Article2023

Evaluating prospective study registration and result reporting of trials conducted in Canada from 2009 to 2019

Mohsen Alayche, Kelly D. Cobey, Jeremy Y. Ng, Clare L. Ardern, Karim Khan, An‐Wen Chan, Ryan Chow, Mouayad Masalkhi, Ana Patricia Ayala, Sanam Ebrahimzadeh, Jason Ghossein, Ibrahim Alayche, Jessie V. Willis, David Moher

Preprint2022

Evaluating prospective study registration and result reporting of trials conducted in Canada from 2009-2019

Mohsen Alayche, Kelly D. Cobey, Jeremy Y. Ng, Clare L. Ardern, Karim M. Khan, An‐Wen Chan, Ryan Chow, Mouayad Masalkhi, Ana Patricia Ayala, Sanam Ebrahimzadeh, Jason Ghossein, Ibrahim Alayche, Jessie V. Willis, David Moher